FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249776918> ?p ?o ?g. }

• W4249776918 abstract "Abstract Purpose In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin. Methods This retrospective descriptive analysis included patients with lymphoma who received PLD treatment (≥ 2 cycles of chemotherapy) at our cancer centre and had complete follow-up data from January 2016 to February 2020. Clinical, laboratory data, as well as the occurrence of hand-foot syndrome (incidence, location, severity, impact on follow-up chemotherapy) were obtained. The primary end point was the incidence of hand-foot syndrome, which was classified according to the Common Terminology Criteria for Adverse Events (Version 4.0). A multivariate logistic regression analysis was used to identify risk factors for hand-foot syndrome in patients with lymphoma using doxorubicin liposomes. Findings A total of 167 patients met the inclusion criteria. 58 developed HFS, of which 45 occurred after the second course of chemotherapy. The multivariate logistic regression analysis revealed that a dose increase of pegylated liposomal doxorubicin and hepatobiliary dysfunction were significantly associated with an increased risk for hand-foot syndrome(dose intensity, OR= 6.479; 95% CI, 1.431-29.331 [P =0.015]; history of gallstones, OR = 14.144, 95% CI, 1.512-132.346 [P =0.020]; alanine aminotransferase, OR = 1.194, 95% CI, 1.056-1.350 [P =0.005]; alanine aminotransferase, OR = 1.162, 95% CI, 1.010-1.336 [P =0.035]; and glutamine transpeptidase, OR = 1.092, 95% CI, 1.016-1.174 [P =0.018]). Implications These findings contribute to the risk assessment of patients with lymphoma before using pegylated liposomal doxorubicin. For patients with the above risk factors, preventive measures should be taken in advance to reduce the incidence of HFS." @default.
• W4249776918 created "2022-05-12" @default.
• W4249776918 creator A5024418323 @default.
• W4249776918 creator A5028165423 @default.
• W4249776918 creator A5029976570 @default.
• W4249776918 creator A5042401600 @default.
• W4249776918 creator A5046898019 @default.
• W4249776918 creator A5050006970 @default.
• W4249776918 creator A5060261172 @default.
• W4249776918 creator A5060296554 @default.
• W4249776918 creator A5068694927 @default.
• W4249776918 creator A5069456938 @default.
• W4249776918 creator A5087998125 @default.
• W4249776918 date "2021-04-19" @default.
• W4249776918 modified "2023-10-16" @default.
• W4249776918 title "High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin : a retrospective study" @default.
• W4249776918 doi "https://doi.org/10.21203/rs.3.rs-411901/v1" @default.
• W4249776918 hasPublicationYear "2021" @default.
• W4249776918 type Work @default.
• W4249776918 citedByCount "0" @default.
• W4249776918 crossrefType "posted-content" @default.
• W4249776918 hasAuthorship W4249776918A5024418323 @default.
• W4249776918 hasAuthorship W4249776918A5028165423 @default.
• W4249776918 hasAuthorship W4249776918A5029976570 @default.
• W4249776918 hasAuthorship W4249776918A5042401600 @default.
• W4249776918 hasAuthorship W4249776918A5046898019 @default.
• W4249776918 hasAuthorship W4249776918A5050006970 @default.
• W4249776918 hasAuthorship W4249776918A5060261172 @default.
• W4249776918 hasAuthorship W4249776918A5060296554 @default.
• W4249776918 hasAuthorship W4249776918A5068694927 @default.
• W4249776918 hasAuthorship W4249776918A5069456938 @default.
• W4249776918 hasAuthorship W4249776918A5087998125 @default.
• W4249776918 hasBestOaLocation W42497769181 @default.
• W4249776918 hasConcept C120665830 @default.
• W4249776918 hasConcept C121332964 @default.
• W4249776918 hasConcept C126322002 @default.
• W4249776918 hasConcept C141071460 @default.
• W4249776918 hasConcept C143998085 @default.
• W4249776918 hasConcept C167135981 @default.
• W4249776918 hasConcept C197934379 @default.
• W4249776918 hasConcept C2776694085 @default.
• W4249776918 hasConcept C2777793932 @default.
• W4249776918 hasConcept C2781303535 @default.
• W4249776918 hasConcept C61511704 @default.
• W4249776918 hasConcept C71924100 @default.
• W4249776918 hasConcept C90924648 @default.
• W4249776918 hasConceptScore W4249776918C120665830 @default.
• W4249776918 hasConceptScore W4249776918C121332964 @default.
• W4249776918 hasConceptScore W4249776918C126322002 @default.
• W4249776918 hasConceptScore W4249776918C141071460 @default.
• W4249776918 hasConceptScore W4249776918C143998085 @default.
• W4249776918 hasConceptScore W4249776918C167135981 @default.
• W4249776918 hasConceptScore W4249776918C197934379 @default.
• W4249776918 hasConceptScore W4249776918C2776694085 @default.
• W4249776918 hasConceptScore W4249776918C2777793932 @default.
• W4249776918 hasConceptScore W4249776918C2781303535 @default.
• W4249776918 hasConceptScore W4249776918C61511704 @default.
• W4249776918 hasConceptScore W4249776918C71924100 @default.
• W4249776918 hasConceptScore W4249776918C90924648 @default.
• W4249776918 hasLocation W42497769181 @default.
• W4249776918 hasLocation W42497769182 @default.
• W4249776918 hasOpenAccess W4249776918 @default.
• W4249776918 hasPrimaryLocation W42497769181 @default.
• W4249776918 hasRelatedWork W2002120878 @default.
• W4249776918 hasRelatedWork W2003938723 @default.
• W4249776918 hasRelatedWork W2004158172 @default.
• W4249776918 hasRelatedWork W2047967234 @default.
• W4249776918 hasRelatedWork W2066797670 @default.
• W4249776918 hasRelatedWork W2395544729 @default.
• W4249776918 hasRelatedWork W2439875401 @default.
• W4249776918 hasRelatedWork W2793680908 @default.
• W4249776918 hasRelatedWork W3084079294 @default.
• W4249776918 hasRelatedWork W3154734119 @default.
• W4249776918 isParatext "false" @default.
• W4249776918 isRetracted "false" @default.
• W4249776918 workType "article" @default.